Value through Innovation27 July 2016

Clinical Study Results

  • Eschscholzia californica - Sleep Initiation and Maintenance Disorders
    Clinical Study Number 1120.2
    Study Indication Sleep Initiation and Maintenance Disorders
    Product Eschscholzia californica
    Generic Name Eschscholzia californica
    Lab Code
    Clinical Phase III
    Study Title

    A double-blind randomised, placebo controlled study to assess the efficacy and the safety of Eschscholtzia Californica 1000 mg per day in treating primary insomnia during a 28 day treatment duration.

    Study Document Trial synopsis 1120.2 english
  • Eschscholzia californica - Pain
    Clinical Study Number 1120.3
    Study Indication Pain
    Product Eschscholzia californica
    Generic Name Eschscholzia californica
    Lab Code
    Clinical Phase II
    Study Title

    Short term double blind randomised controlled study to assess the kinetic of the analgesic effect and the tolerability of Eschscholtzia Califomica 500 mg and 1000 mg versus ibuprofen 200 mg and placebo in the treatment of pain after surgery of the third molar.

    Study Document Trial synopsis 1120.3_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.